The Proteomic Analysis of Platelet Extracellular Vesicles in Diabetic Patients by nanoLC-MALDI-MS/MS and nanoLC-TIMS-MS/MS
Molecules · 2025
DOI: 10.3390/molecules30061384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Joanna Kasprzyk-Pochopień und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of High-Resolution Mass Spectrometry, Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland. Hauptthemen laut MEDLINE: Extracellular Vesicles, Proteomics, Blood Platelets, Diabetes Mellitus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Platelet extracellular vesicles (PEVs) are emerging as key biomarkers in diabetes mellitus (DM), reflecting altered platelet function and coagulation pathways. This study compares two proteomic techniques—nanoLC-MALDI-MS/MS and nanoLC-TIMS-MS/MS—for analyzing PEVs in diabetic patients, to assess their potential for biomarker discovery. PEVs were isolated from platelet-rich plasma and characterized using tunable resistive pulse sensing (TRPS), Fourier-transform infrared (FTIR) spectroscopy, and transmission electron microscopy (TEM). Proteomic analyses identified significant differences in protein expression between diabetic and non-diabetic individuals, with nanoLC-TIMS-MS/MS demonstrating superior sensitivity by detecting 97% more unique proteins than nanoLC-MALDI-MS/MS. Key differentially expressed proteins included apolipoproteins and oxidative stress markers, which may contribute to platelet dysfunction and cardiovascular complications in DM. Sex-specific variations in protein expression were also observed, highlighting potential differences in disease progression between male and female patients. The integration of advanced proteomic methodologies provides novel insights into the role of PEVs in diabetes pathophysiology, underscoring their diagnostic and therapeutic potential. These findings pave the way for improved biomarker-based strategies for early detection and monitoring of diabetic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of High-Resolution Mass Spectrometry, Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland.
- Department of Medical Physics, M. Smoluchowski Institute of Physics, Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, 30-348 Krakow, Poland.
- Department of Analytical Chemistry and Biochemistry, Faculty of Materials Science and Ceramics, AGH University of Krakow, 30-059 Krakow, Poland.
- Department of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland.
- Total-Body Jagiellonian-PET Laboratory, Jagiellonian University, 30-348 Krakow, Poland.
- Center for Theranostics, Jagiellonian University, 31-501 Krakow, Poland.
ORCID-Profile: Joanna Kasprzyk-Pochopień, Przemysław Mielczarek, Radosław Porada, Ewa Stępień, Wojciech Piekoszewski
Zitieren
APA
Kasprzyk-Pochopień, J., Kamińska, A., Mielczarek, P., Porada, R., Stępień, E., & Piekoszewski, W. (2025). The Proteomic Analysis of Platelet Extracellular Vesicles in Diabetic Patients by nanoLC-MALDI-MS/MS and nanoLC-TIMS-MS/MS. Molecules. https://doi.org/10.3390/molecules30061384
Vancouver
Kasprzyk-Pochopień J, Kamińska A, Mielczarek P, Porada R, Stępień E, Piekoszewski W. The Proteomic Analysis of Platelet Extracellular Vesicles in Diabetic Patients by nanoLC-MALDI-MS/MS and nanoLC-TIMS-MS/MS. Molecules. 2025. doi:10.3390/molecules30061384
BibTeX
@article{KasprzykPochopie2025,
author = {Kasprzyk-Pochopień, Joanna and Kamińska, Agnieszka and Mielczarek, Przemysław and Porada, Radosław and Stępień, Ewa and Piekoszewski, Wojciech},
title = {The Proteomic Analysis of Platelet Extracellular Vesicles in Diabetic Patients by nanoLC-MALDI-MS/MS and nanoLC-TIMS-MS/MS},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30061384}
}
EUVIMED